July 2026 Converting an open-ended regulatory exposure into a predictable monthly cost Intro Compliance spending competes with every other line in a growing company's budget, and for US companies selling into Europe, the EU Data Representative ('EU Data Rep.') requirement under Article 27 GDPR can look like one more cost. Framed correctly, it is the opposite: one of the cheapest pieces of risk mitigation available, because the exposure it removes is large, quantifiable and gr

June 2026 'We're too small', 'we don't charge EU users', 'our vendor handles it': why these assumptions fail Intro Article 27 GDPR requires organisations without an EU establishment that offer goods or services to individuals in the EU, or monitor their behaviour, to appoint an EU Data Representative ('EU Data Rep.'). In our work with US companies, the obligation is rarely ignored deliberately. More often, it is missed because of a handful of persistent myths. Here are the fi

June 2026 Article 27 GDPR applies to far more US life sciences companies than many realise Intro The extraterritorial reach of the General Data Protection Regulation (GDPR) is well known, yet many US pharma and biotech companies are surprised to learn that it applies to them, and even more surprised to learn about Article 27. If your organisation has no establishment in the EU but engages with EU based consumers, patients or trial participants, you are likely required to a

May 2026 Intro The extraterritorial reach of the General Data Protection Regulation (GDPR) continues to capture organisations operating outside the European Union. While many recognise that the GDPR may apply to their activities, a critical obligation is often overlooked: the requirement to appoint an EU Data Representative under Article 27. This provision ensures that EU regulators and individuals have an accessible point of contact, reinforcing the GDPR’s core principles o

Art 27 GDPR, EU Data Rep, GDPR enforcemen